Bio Protocol vs Measurable Data Token — how do they compare? Bio Protocol trades at Rp513.51 (market cap Rp1,15T, Rp260,42M 24h volume), while Measurable Data Token trades at Rp69.73 (market cap Rp72,67M, Rp18,99M 24h volume). The key difference: Bio Protocol is far larger — about 15825× Measurable Data Token's market cap, and Bio Protocol's supply is capped (2,2B / 3,3B BIO (68%)) while Measurable Data Token's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Measurable Data Token for 18 Days on average.
| BIO | MDT | |
|---|---|---|
Market Cap | Rp1,15T | Rp72,67M |
Volume (24h) | Rp260,42M | Rp18,99M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 676,2M MDT |
Typical Hold Time | 16 Days | 18 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp514.67 with a market cap of Rp1.15 trillion, showing a bearish technical signal as moving averages indicate selling pressure. The token's circulating supply is 2.2 million out of 3.3 million, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though no major protocol upgrades were reported in the last month.
Overall outlook remains cautious due to bearish technicals and neutral oscillators. Key opportunities include potential rebound from oversold RSI levels near support at Rp474. Major risks involve low liquidity, regulatory uncertainty in Indonesia, and high volatility typical of small-cap cryptocurrencies.
Measurable Data Token (MDT) shows a market cap of Rp72.67M with 676.2 million tokens in circulation and an average hold time of 18 days, indicating moderate token velocity. The asset lacks current price data, making technical assessment challenging, but the circulating supply suggests established distribution. Recent crypto market conditions and token-specific developments will influence short-term price action, while long-term trends depend on ecosystem growth and adoption metrics.
Overall outlook is neutral with limited data; key opportunities include potential utility expansion and network adoption, but major risks involve low liquidity, price volatility, and regulatory uncertainty. Investors should monitor on-chain activity and exchange listings for clearer direction.
What Pluang investors did over the last 30 days
No sentiment data available yet.
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Measurable Data Token (MDT) is a decentralized data exchange ecosystem connecting users, data providers, and data buyers and denominates the value of data.
Read more on MDT →